About Raysun
An Integrated Platform for Complex Biopharmaceutical Programs
Raysun Biopharma is developing a project-led platform in Vientiane to support peptide and oligonucleotide programs from API development through sterile formulation and finished dosage forms. Each opportunity is assessed through technical, quality and regulatory review before scope, timelines and deliverables are defined.
Peptide API Development
Project-specific development pathways for peptide APIs, including process, analytical and scale-up planning for qualified pharmaceutical programs.
Oligonucleotide Development
Development planning for selected oligonucleotide APIs and NCE programs, aligned with molecule requirements, analytical strategy and intended scale.
Sterile Formulation & Fill-Finish
Formulation and drug-product development pathways for lyophilized vials, cartridges and other suitable sterile presentations.
Concept imagery for visual presentation; not presented as documentary photography of current Raysun operations.
Why Choose Raysun?
Why Biopharma Teams Work with Raysun
Raysun brings API development, formulation and sterile drug-product planning into one project-led pathway. Each program is evaluated against technical feasibility, quality expectations and its intended clinical or commercial stage before scope is confirmed.
01
Project-Specific Development Planning
- Technical assessment tailored to each molecule and target product profile
- Clearly defined project scope, timelines and deliverables
- Development planning aligned with clinical or commercial objectives
- Transparent communication throughout project evaluation and execution
02
Integrated API-to-Drug-Product Pathway
- Connected planning for peptide and oligonucleotide API programs
- Formulation development based on molecule and dosage-form requirements
- Sterile fill-finish pathways for suitable vial and cartridge presentations
- Coordinated technology-transfer and manufacturing-readiness planning
03
Quality & Regulatory Alignment
- Quality considerations incorporated from the beginning of development
- Analytical strategy coordinated with process and formulation activities
- Risk-based technical reviews before major project milestones
- Documentation designed to support qualified international programs
Our Services
Our Services
Project-based development pathways connecting peptide and oligonucleotide APIs with formulation, analytical support and sterile drug-product planning for qualified biopharmaceutical programs.
Peptide CDMO Services
Project-based peptide API development, analytical planning and manufacturing pathways for qualified programs.
GMP Oligo Services
Integrated planning for selected oligonucleotide API and NCE programs, from technical review through scale-up readiness.
FTE Services
Dedicated project teams and defined work packages for longer-term peptide and oligonucleotide development programs.
Discovery Services
Early-stage peptide synthesis, feasibility assessment and analytical support for research and discovery projects.
Generic APIs
Technical evaluation and development planning for selected peptide, oligonucleotide and other API programs.
Formulation
Formulation and sterile drug-product pathways for suitable vial, cartridge and finished dosage-form presentations.